Class IA antiarrhythmics such as disopyramide, quinidine, and procainamide are associated with QT prolongation and torsades de pointes TdP.
Clinical practice guidelines suggest a 3-day regimen may be appropriate for women with uncomplicated cystitis; however, quinolones should be considered alternative therapy. Post-marketing surveillance has identified very rare cases of ventricular arrhythmias including TdP, usually in patients with severe underlying proarrhythmic conditions.
This drug may make you dizzy. Elizabeth Davis is GoodRx's medical editor and consumer savings expert. Got a topic you'd like us to discuss?
Moderate Use tretinoin with caution in patients who are also taking drugs known to be photosensitizers, such as ofloxacin, as concomitant use may augment phototoxicity. Systemic quinolones, including ofloxacin, have been associated with hypersensitivity reactions, even following a single dose.
Oxygen and airway management, including intubation, should be administered as clinically indicated. If someone swallows ofloxacin otic, call your local poison control center at Foscarnet has been associated with postmarketing reports of both QT prolongation and torsade de pointes TdP. Cross-resistance has been observed between ofloxacin and other fluoroquinolones.
The CDC recommends mg PO twice daily for 7 days as an alternative to first line agents doxycycline or azithromycin. The mean increase in QTc is about 6 milliseconds, measured at the tmax of the maximum dosage mg PO twice daily. No changes in hearing function occurred in 30 pediatric subjects treated with ofloxacin otic and tested for audiometric parameters. If you experience any of these symptoms, stop using ofloxacin otic call your doctor immediately: Do not let anyone else use your medication.
Major Concurrent use of saquinavir boosted with ritonavir and ofloxacin should be avoided due to an increased risk for QT prolongation and torsade de pointes TdP.
Major Enteral feedings may decrease the serum concentrations of ofloxacin if administered concurrently. Granisetron has been associated with QT prolongation. Discontinue quinolones at the first sign of tendon inflammation or tendon pain as these are symptoms that may precede rupture of the tendon.
Other side effects were: Other treatment-related adverse reactions reported in subjects with non-intact tympanic membranes included: Atomoxetine is considered a drug with a possible risk of torsade de pointes TdP. For ophthalmic use only.
Acute cardiotoxicity can occur during administration of daunorubicin or doxorubicin; cumulative, dose-dependent cardiomyopathy may also occur. This product is not available in the United States.
How should this medicine be used?
Females, elderly patients, patients with diabetes, thyroid disease, malnutrition, alcoholism, or hepatic dysfunction may also be at increased risk for QT prolongation.
This created a backorder situation at the start, but eventually lead to all bottle sizes being discontinued—with the manufacturers unable to provide a reason. Tier Description 1 This drug is available at the lowest co-pay.